Risk factors for the COVID‐19 severity and its correlation with viral shedding: A retrospective cohort study

Coronavirus disease 2019 (COVID‐19) have become a pandemic in the world. This study is aim to explore risk factors for COVID‐19 severity in the early stage and the correlation between the viral shedding and COVID‐19 severity. We included inpatient with laboratory confirmed COVID‐19 who had been discharged by 9 March 2020. The medical record data and dynamic change of biochemical indicators in‐hospital were compared between common and severe patients. Eighty patients were included in this study. Multivariable regression demonstrated increasing odds of severity associated with the duration of fever (odds ratio [OR], 1.42; 95% confidence interval [CI], 1.10‐1.82, per day increase; P = .007), C‐reactive protein (CRP) (OR, 1.26; 95% CI, 1.04‐1.52; P = .02), and PO2 < 80 mm Hg (28.07, 95% CI, 1.50‐524.12; P = .026) on admission. We found severe acute respiratory syndrome coronavirus 2 viral RNA could be long‐term presence in respiratory tract and fecal sample, up to 43 and 46 days, respectively. However, the duration of viral shedding have no correlation with the COVID‐19 severity. The duration of fever, elevated CRP and PO2 < 80 mm Hg on admission were associated with the COVID‐19 severity in the early stage and there is no correlation between the viral shedding and COVID‐19 severity.

[1]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[2]  Guo‐Jun Zhang,et al.  The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China , 2020, European Respiratory Journal.

[3]  Andrew Steptoe,et al.  Stress and cardiovascular disease , 2012, Nature Reviews Cardiology.

[4]  S. Zhang,et al.  Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series , 2020, BMJ.

[5]  Jun Liu,et al.  Factors associated with prolonged viral RNA shedding in patients with COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Hong Shan,et al.  Evidence for Gastrointestinal Infection of SARS-CoV-2 , 2020, Gastroenterology.

[7]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[8]  C. Nemeroff,et al.  Heartache and heartbreak—the link between depression and cardiovascular disease , 2012, Nature Reviews Cardiology.

[9]  A. Schuchat,et al.  COVID-19: towards controlling of a pandemic , 2020, The Lancet.

[10]  G. Semenza,et al.  Hypoxia-inducible factor 1 and cardiovascular disease. , 2014, Annual review of physiology.

[11]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[12]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[13]  G. Semenza,et al.  Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. , 2014, Annual review of pathology.

[14]  R. Gao,et al.  Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19 , 2020, Science of The Total Environment.

[15]  Andrew Steptoe,et al.  Effects of stress on the development and progression of cardiovascular disease , 2018, Nature Reviews Cardiology.

[16]  O. Tsang,et al.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.

[17]  H. Shan,et al.  Prolonged presence of SARS-CoV-2 viral RNA in faecal samples , 2020, The Lancet Gastroenterology & Hepatology.

[18]  Sharukh Lokhandwala,et al.  Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.

[19]  D. Musher,et al.  Acute pneumonia and the cardiovascular system , 2013, The Lancet.

[20]  Qiurong Ruan,et al.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.

[21]  Xiang Xie,et al.  COVID-19 and the cardiovascular system , 2020, Nature Reviews Cardiology.

[22]  Wenling Wang,et al.  The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice , 2020, Nature.

[23]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[24]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[25]  T. Marrie,et al.  Community-Acquired Pneumonia Requiring Admission to an Intensive Care Unit: A Descriptive Study , 2007, Medicine.

[26]  Peter Johansson,et al.  Depression and cardiovascular disease: a clinical review. , 2014, European heart journal.

[27]  T. Bai,et al.  Risk factors for viral RNA shedding in COVID-19 patients , 2020, European Respiratory Journal.

[28]  Joel E Dimsdale,et al.  Psychological stress and cardiovascular disease. , 2008, Journal of the American College of Cardiology.

[29]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.